Insider Selling: Integral Ad Science (NASDAQ:IAS) CAO Sells 3,527 Shares of Stock

Key Points

• Integral Ad Science's CAO, Alexis Gil II, sold 3,527 shares of stock at an average price of $10.18 on October 3rd, reducing their ownership by 2.46%.
• The stock price for Integral Ad Science has seen a 0.1% decline, reaching $10.19, with a market cap of approximately $1.69 billion.
• Analysts have varying ratings for the stock, with an average target price of $12.81 and most analysts rating it as a "Hold."

Integral Ad Science Holding Corp. (NASDAQ:IAS - Get Free Report) CAO Alexis Gil II sold 3,527 shares of the business's stock in a transaction dated Friday, October 3rd. The shares were sold at an average price of $10.18, for a total value of $35,904.86. Following the completion of the sale, the chief accounting officer owned 139,621 shares in the company, valued at approximately $1,421,341.78. This trade represents a 2.46% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.

Alexis Gil II also recently made the following trade(s):

• On Thursday, October 2nd, Alexis Gil II sold 1,992 shares of Integral Ad Science stock. The shares were sold at an average price of $10.18, for a total value of $20,278.56.
• On Wednesday, September 24th, Alexis Gil II sold 25,901 shares of Integral Ad Science stock. The shares were sold at an average price of $10.18, for a total value of $263,672.18.

Integral Ad Science Stock Down 0.1%

Shares of NASDAQ:IAS traded down $0.01 during midday trading on Tuesday, reaching $10.19. The company had a trading volume of 8,027,251 shares, compared to its average volume of 6,408,295. The business's 50 day moving average price is $8.97 and its 200 day moving average price is $8.22. The stock has a market cap of $1.69 billion, a PE ratio of 29.97, a P/E/G ratio of 1.45 and a beta of 1.60. Integral Ad Science Holding Corp. has a 1-year low of $6.26 and a 1-year high of $13.62.

Integral Ad Science (NASDAQ:IAS - Get Free Report) last released its earnings results on Thursday, August 7th. The company reported $0.07 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.04 by $0.03. The business had revenue of $149.20 million for the quarter, compared to the consensus estimate of $143.02 million. Integral Ad Science had a return on equity of 5.00% and a net margin of 9.79%. Integral Ad Science has set its Q3 2025 guidance at EPS. FY 2025 guidance at EPS. On average, research analysts expect that Integral Ad Science Holding Corp. will post 0.26 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Integral Ad Science

A number of institutional investors have recently made changes to their positions in the company. Vanguard Group Inc. boosted its holdings in shares of Integral Ad Science by 0.5% during the first quarter. Vanguard Group Inc. now owns 9,090,229 shares of the company's stock worth $73,267,000 after acquiring an additional 41,683 shares during the period. Sunriver Management LLC boosted its holdings in shares of Integral Ad Science by 8.0% during the second quarter. Sunriver Management LLC now owns 8,822,914 shares of the company's stock worth $73,318,000 after acquiring an additional 656,140 shares during the period. P2 Capital Partners LLC boosted its holdings in shares of Integral Ad Science by 2.1% during the second quarter. P2 Capital Partners LLC now owns 4,910,000 shares of the company's stock worth $40,802,000 after acquiring an additional 100,000 shares during the period. Corvex Management LP bought a new stake in shares of Integral Ad Science during the first quarter worth approximately $21,101,000. Finally, Aberdeen Group plc boosted its holdings in shares of Integral Ad Science by 12.7% during the first quarter. Aberdeen Group plc now owns 1,994,980 shares of the company's stock worth $16,080,000 after acquiring an additional 224,153 shares during the period. Institutional investors own 95.78% of the company's stock.

Analysts Set New Price Targets

A number of analysts recently issued reports on IAS shares. Barclays lifted their target price on Integral Ad Science from $9.00 to $10.00 and gave the company an "equal weight" rating in a research report on Friday, August 8th. Craig Hallum downgraded Integral Ad Science from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, September 24th. BMO Capital Markets set a $10.30 price target on Integral Ad Science and gave the stock a "market perform" rating in a research report on Wednesday, September 24th. Weiss Ratings reissued a "hold (c-)" rating on shares of Integral Ad Science in a research report on Saturday, September 27th. Finally, Loop Capital downgraded Integral Ad Science from a "buy" rating to a "hold" rating and set a $10.30 price target on the stock. in a research report on Wednesday, September 24th. One research analyst has rated the stock with a Buy rating and fourteen have assigned a Hold rating to the company's stock. According to MarketBeat.com, the stock has an average rating of "Hold" and a consensus target price of $12.81.

Integral Ad Science Company Profile

Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.